Tecemotide (L-BLP25) in Rectal Cancer
Clinical trial NCT01507103 · COMPLETED
Trial details
- NCT number
- NCT01507103
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-06-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.